Abstract:Necroptosis is a form of programmed cell death executed by receptor-interacting serine/threonine protein kinase 1 (RIPK1), RIPK3, and mixed lineage kinase domain-like (MLKL). Platelets are circulating cells that play central roles in haemostasis and pathological thrombosis. In this study we demonstrate seminal contribution of MLKL in transformation of agonist-stimulated platelets to active haemostatic units progressing eventually to necrotic death on a temporal scale, thus attributing a yet unrecognized fundamental role to MLKL in platelet biology. Physiological agonists like thrombin instigated phosphorylation and subsequent oligomerization of MLKL in platelets in a RIPK3-independent but phosphoinositide 3-kinase (PI3K)/AKT-dependent manner. Inhibition of MLKL significantly curbed agonist-induced haemostatic responses in platelets that included platelet aggregation, integrin activation, granule secretion, procoagulant surface generation, rise in intracellular calcium, shedding of extracellular vesicles, platelet-leukocyte interactions and thrombus formation under arterial shear. MLKL inhibition, too, prompted impairment in mitochondrial oxidative phosphorylation and aerobic glycolysis in stimulated platelets, accompanied with disruption in mitochondrial transmembrane potential, augmented proton leak and drop in both mitochondrial calcium as well as ROS. These findings underscore the key role of MLKL in sustaining OXPHOS and aerobic glycolysis that underlie energy-intensive platelet activation responses. Prolonged exposure to thrombin provoked oligomerization and translocation of MLKL to plasma membranes forming focal clusters that led to progressive membrane permeabilization and decline in platelet viability, which was prevented by inhibitors of PI3K/MLKL. In summary, MLKL plays vital role in transitioning of stimulated platelets from relatively quiescent cells to functionally/metabolically active prothrombotic units and their ensuing progression to necroptotic death.

Phosphorylation-dependent pseudokinase domain dimerization drives full-length MLKL oligomerization

The MLKL Channel in Necroptosis is an Octamer Formed by Tetramers in a Dyadic Process.

Conformational switching of the pseudokinase domain promotes human MLKL tetramerization and cell death by necroptosis

The MLKL kinase-like domain dimerization is an indispensable step of mammalian MLKL activation in necroptosis signaling

The brace helices of MLKL mediate interdomain communication and oligomerisation to regulate cell death by necroptosis

Death at a funeral: Activation of the dead enzyme, MLKL, to kill cells by necroptosis

MLKL forms disulfide bond-dependent amyloid-like polymers to induce necroptosis

Human RIPK3 maintains MLKL in an inactive conformation prior to cell death by necroptosis

Oligomerization-driven MLKL ubiquitylation antagonizes necroptosis

Diverse sequence determinants control human and mouse receptor interacting protein 3 (RIP3) and mixed lineage kinase domain-like (MLKL) interaction in necroptotic signaling.

Characterization of RIPK3-mediated phosphorylation of the activation loop of MLKL during necroptosis

Mixed Lineage Kinase Domain-Like Protein MLKL Causes Necrotic Membrane Disruption Upon Phosphorylation by RIP3.

Uncovering human mixed lineage kinase domain-like activation in necroptosis

Biological events and molecular signaling following MLKL activation during necroptosis

Direct Activation of Human MLKL by a Select Repertoire of Inositol Phosphate Metabolites

Locking mixed-lineage kinase domain-like protein in its auto-inhibited state prevents necroptosis

Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death

Necrosome core machinery: MLKL

Necroptosis executioner MLKL plays pivotal roles in agonist-induced platelet prothrombotic responses and lytic cell death in a temporal order

Structural Insights into RIP3-Mediated Necroptotic Signaling

Acylation of MLKL Impacts Its Function in Necroptosis